Viewing Study NCT04711850


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2025-12-24 @ 5:24 PM
Study NCT ID: NCT04711850
Status: TERMINATED
Last Update Posted: 2025-05-28
First Post: 2021-01-13
Is Possible Gene Therapy: False
Has Adverse Events: True

Brief Title: An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
Sponsor: Hansa Biopharma AB
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-01-20
Start Date Type: ACTUAL
Primary Completion Date: 2023-03-30
Primary Completion Date Type: ACTUAL
Completion Date: 2023-03-30
Completion Date Type: ACTUAL
First Submit Date: 2021-01-13
First Submit QC Date: None
Study First Post Date: 2021-01-15
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-02-25
Results First Submit QC Date: None
Results First Post Date: 2025-05-11
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-05-16
Last Update Post Date: 2025-05-28
Last Update Post Date Type: ACTUAL